News FDA experts to vote on Spark's groundbreaking gene therapy Luxturna could be single life-changing injection
News Orchard’s gene therapy gains UK ‘promising innovative medici... A UK biotech start-up has gained a sought after ‘promising innovative medicine’ (PIM) designation for its ultra-rare disease gene therapy.
News Spark files revolutionary gene therapy with FDA Luxturna granted six-month priority review by FDA.
News Submission completed, Spark sets sight on first ever US gene... Spark Therapeutics has completed the rolling submission of gene therapy product voretigene neparvovec, for patients with a rare genetic form of blindness.
News Sangamo and new gene therapy partner Pfizer lifted by FDA fa... Sangamo Therapeutics has been granted a fast track designation from the FDA for SB-525, its gene therapy candidate for haemophilia A.
News Spark and Pfizer's haemophilia gene therapy gets European PR... Decision based on promising data from ongoing phase 1/2 trial.
News UK offers meningitis jab to young people after outbreak The UK government has responded to calls to broaden vaccinations for meningitis B, offering the jab to "thousands" of young people this summer.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
